专利号:US-11224566-B2 优先权日:2016-12-29 标题 :Composition comprising a crosslinked hyaluronic acid (HA) in combination with a low-molecular HA and/or an agent stimulating endogenous HA synthesis 发明人:MALLARD CLAIRE; RIVAL YVES 权利人:Galderma Holding SA 摘要:A composition comprising, in a physiologically acceptable medium, a crosslinked hyaluronic acid (HA), having a degree of modification less than 1.9 mole %; a HA with a molecular weight of about 50 kDa or less; and/or an agent stimulating endogenous HA synthesis. Also disclosed is a cosmetic use of such composition in skin care and/or anti-ageing treatment.
专利号:US-12036300-B2 优先权日:2021-03-31 标题:Methods and compositions for improving skin 发明人:LIAO I-CHIEN; BRIEVA PATRICIA; JUCHAUX FRANCK; BOUEZ CHARBEL; ZHENG QIAN; QIAN KUN 权利人:OREAL 摘要:A method for managing skin tone comprising reducing the synthesis of melanin by applying a skin treatment composition to skin. The skin treatment composition may include about 0.1 to about 25 wt. % of acetyl trifluoromethylphenyl valylglycine; about 0.5 to about 30 wt. % of a polyol; about 0.1 to about 30 wt. % of a silicone, fatty compound, or a mixtures thereof, wherein the skin treatment composition is an emulsion, and all weight percentages are based on the total weight of the skin treatment composition.
专利号:US-2016271177-A1 优先权日:2015-03-18 标 题:Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancer
专利号:EP-2897906-A1 优先权日:2012-09-20 标 题:Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers
专利号:EP-2897906-B1 优先权日:2012-09-20 标题 :Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers 发明人:BENDALE YOGESH NARAYAN; BENDALE VINEETA YOGESH 权利人:BENDALE YOGESH NARAYAN; BENDALE VINEETA YOGESH
专利号:WO-2014045083-A1 优先权日:2012-09-20 标题:Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers
1: Pázmándi K, Szöllősi AG, Fekete T. The "root" causes behind the anti- inflammatory actions of ginger compounds in immune cells. Front Immunol. 2024 Jun 28;15:1400956. doi: 10.3389/fimmu.2024.1400956. 2: Ayustaningwarno F, Anjani G, Ayu AM, Fogliano V. A critical review of Ginger's (Zingiber officinale) antioxidant, anti-inflammatory, and immunomodulatory activities. Front Nutr. 2024 Jun 6;11:1364836. doi: 10.3389/fnut.2024.1364836. 3: Gondokesumo ME, Rasyak MR. In-silico prediction of anti-breast cancer activity of ginger (Zingiber officinale) using machine learning techniques. Breast Dis. 2024;43(1):99-110. doi: 10.3233/BD-249002.
合成参考文献
摘要:Journal of Toxicological Sciences., 16(Suppl 摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198 参考文献:10.1007/s10495-011-0611-3 摘要:Gan FF, Nagle AA, Ang X, Ho OH, Tan SH, Yang H, Chui WK, Chew EH. Shogaols at proapoptotic concentrations induce G(2)/M arrest and aberrant mitotic cell death associated with tubulin aggregation. Apoptosis. 2011 Aug;16(8):856–67. doi: 10.1007/s10495-011-0611-3. 参考文献:10.1007/s10787-021-00902-y 摘要:Bagherniya M, Mahdavi A, Abbasi E, Iranshahy M, Sathyapalan T, Sahebkar A. The effects of phytochemicals and herbal bio-active compounds on tumour necrosis factor-α in overweight and obese individuals: a clinical review. Inflammopharmacology. 2022 Feb;30(1):91–110. doi: 10.1007/s10787-021-00902-y.